• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDIVANCE, INC. ¿ 1725056 UNKNOWN ARCTICGEL PADS; UNKNOWN ARCTIC GEL PAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDIVANCE, INC. ¿ 1725056 UNKNOWN ARCTICGEL PADS; UNKNOWN ARCTIC GEL PAD Back to Search Results
Catalog Number UNKNOWN
Device Problems Improper or Incorrect Procedure or Method (2017); Biocompatibility (2886)
Patient Problems Skin Discoloration (2074); Swelling (2091); Patient Problem/Medical Problem (2688)
Event Type  Injury  
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.
 
Event Description
It was reported that the patient showed skin swelling and slight skin discoloration on day four of therapy, all near the neck area.The patient was still in the neonatal intensive care unit due to other issues and will follow-up on current status of skin issues.Treatment was provided.But it was unknown what treatment was provided.Additional information was received from the sales rep via email on 12aug2020.The representative met with the entire neonate intensive care unit team and reviewed the data as well as their internal process.It was concluded the arctic sun did not cause harm to the patient and the culprit was registered nurse's neglecting to reposition infants in a timely manner.Their hypoxic ischemic encephalopathy (hie) protocol states repositioning q6 and (b)(6) guidelines, as well as published clinical data, clearly stated repositioning q2.The patient was noted to have ¿questionable¿ skin coloring issues during therapy but wasn¿t noticed until end of therapy provided.Completed therapy.He noted therapy was completed on the device.
 
Event Description
It was reported that the patient showed skin swelling and slight skin discoloration on 4th day of therapy, all near the neck area.The patient was still in the neonatal intensive care unit due to other issues and will follow-up on the current status of skin issues.The treatment was provided, but it was unknown what treatment was provided.Additional information was received from the sales rep via email on 12aug2020, the representative met with the entire neonate intensive care unit team and reviewed the data as well as their internal process.It was concluded the arctic sun did not cause harm to the patient and the culprit was registered nurse's neglecting to reposition infants in a timely manner.Their hypoxic ischemic encephalopathy (hie) protocol states repositioning q6 and national association of neonatal nurse's (nann) guidelines, as well as published clinical data, clearly stated repositioning q2.The patient was noted to have questionable skin coloring issues during therapy, but was not noticed until end of the therapy provided.Completed the therapy.They noted that the therapy was completed on the device.
 
Manufacturer Narrative
The reported event was inconclusive, as no sample returned for evaluation.A potential root cause for this failure mode could be due to "materials that are contacting the patient¿s intact skin are not biocompatible".Resulted in bioincompatible reaction.It was unknown whether the device had met specifications.The product used for the treatment purposes.It was unknown whether the product had caused the reported failure.The device was not returned for evaluation.The lot number was unknown, therefore, the device history record could not be reviewed.The product catalog number and lot number for this device was unknown.Therefore, bard was unable to determine the associated labeling to review.The information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN ARCTICGEL PADS
Type of Device
UNKNOWN ARCTIC GEL PAD
Manufacturer (Section D)
MEDIVANCE, INC. ¿ 1725056
321 s taylor ave
louisville CO 80027
MDR Report Key10449668
MDR Text Key204250796
Report Number1018233-2020-05449
Device Sequence Number1
Product Code DWJ
Combination Product (y/n)N
PMA/PMN Number
K142702
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other,use
Type of Report Initial,Followup
Report Date 12/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/03/2020
Initial Date FDA Received08/25/2020
Supplement Dates Manufacturer Received11/10/2020
Supplement Dates FDA Received12/03/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-